Generic Version of Bentyl Injection Launched to Address Shortage

Nexus announced that the Food and Drug Administration (FDA) has approved Dicyclomine HCl Injection, 20mg/2mL, the generic version of Aptalis Pharma’s Bentyl Injection. 

Dicyclomine HCl, an antispasmodic and anticholinergic agent, is currently on the American Society of Health-System Pharmacists’ drug shortage list. The product is indicated for the treatment of functional bowel/irritable bowel syndrome. The intramuscular injection, which is about twice as bioavailable as the oral dosage form, is only used for 1 to 2 days when a patient is unable to take oral medication.

Dicyclomine HCl works by relieving smooth muscle spasms of the gastrointestinal tract through a dual anticholinergic (antimsucarinic) and musculotropic mechanism. 

Dicyclomine Injection is supplied as 20mg/2mL single-dose vials in 5-count cartons and is available immediately; it is latex- and preservative-free.

For more information call (855) 642-2594 or visit NexusPharma.net.